Halpin DM - Search Results

1

Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agusti A. Vogelmeier CF, et al. Among authors: halpin dm. Respirology. 2017 Apr;22(3):575-601. doi: 10.1111/resp.13012. Epub 2017 Mar 7. Respirology. 2017. PMID: 28150362 Free article.

2

Symptoms are an important outcome in chronic obstructive pulmonary disease clinical trials: results of a 3-month comparative study using the Breathlessness, Cough and Sputum Scale (BCSS).

Celli B, Halpin D, Hepburn R, Byrne N, Keating ET, Goldman M. Celli B, et al. Respir Med. 2003 Jan;97 Suppl A:S35-43. Respir Med. 2003. PMID: 12564609 Free article. Clinical Trial.

3

Chronic obstructive pulmonary disease: the disease and its burden to society.

Halpin DM, Miravitlles M. Halpin DM, et al. Proc Am Thorac Soc. 2006 Sep;3(7):619-23. doi: 10.1513/pats.200603-093SS. Proc Am Thorac Soc. 2006. PMID: 16963544 Review.

4

A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators. Tashkin DP, et al. N Engl J Med. 2008 Oct 9;359(15):1543-54. doi: 10.1056/NEJMoa0805800. Epub 2008 Oct 5. N Engl J Med. 2008. PMID: 18836213 Free article. Clinical Trial.

5

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.

Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP; UPLIFT investigators. Decramer M, et al. Lancet. 2009 Oct 3;374(9696):1171-8. doi: 10.1016/S0140-6736(09)61298-8. Epub 2009 Aug 27. Lancet. 2009. PMID: 19716598 Clinical Trial.

6

Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial.

Troosters T, Celli B, Lystig T, Kesten S, Mehra S, Tashkin DP, Decramer M; Uplift Investigators. Troosters T, et al. Eur Respir J. 2010 Jul;36(1):65-73. doi: 10.1183/09031936.00127809. Epub 2010 Feb 25. Eur Respir J. 2010. PMID: 20185426 Free article. Clinical Trial.

7

Budesonide/formoterol vs. salmeterol/fluticasone in COPD: a systematic review and adjusted indirect comparison of pneumonia in randomised controlled trials.

Halpin DM, Gray J, Edwards SJ, Morais J, Singh D. Halpin DM, et al. Int J Clin Pract. 2011 Jul;65(7):764-74. doi: 10.1111/j.1742-1241.2011.02685.x. Int J Clin Pract. 2011. PMID: 21676119 Review.

8

Risk of nonlower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT® trial.

Halpin DM, Decramer M, Celli B, Kesten S, Leimer I, Tashkin DP. Halpin DM, et al. Lung. 2011 Aug;189(4):261-8. doi: 10.1007/s00408-011-9301-8. Epub 2011 Jun 16. Lung. 2011. PMID: 21678045 Free PMC article.

9

Exacerbation frequency and course of COPD.

Halpin DM, Decramer M, Celli B, Kesten S, Liu D, Tashkin DP. Halpin DM, et al. Int J Chron Obstruct Pulmon Dis. 2012;7:653-61. doi: 10.2147/COPD.S34186. Epub 2012 Sep 21. Int J Chron Obstruct Pulmon Dis. 2012. PMID: 23055714 Free PMC article.

10

Annual rates of change in pre- vs. post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPD.

Tashkin DP, Li N, Halpin D, Kleerup E, Decramer M, Celli B, Elashoff R. Tashkin DP, et al. Respir Med. 2013 Dec;107(12):1904-11. doi: 10.1016/j.rmed.2013.08.001. Epub 2013 Aug 22. Respir Med. 2013. PMID: 23972968 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

232 results

Search Page

Filters